UK markets close in 6 hours 24 minutes

Viking Therapeutics, Inc. (VKTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
68.86+3.79 (+5.82%)
At close: 04:00PM EDT
69.27 +0.41 (+0.60%)
After hours: 07:57PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
76,901
63,806
54,234
44,981
31,931
Selling general and administrative
37,462
37,021
16,121
10,701
10,731
Total operating expenses
114,363
100,827
70,355
55,682
42,662
Operating income or loss
-114,363
-100,827
-70,355
-55,682
-42,662
Total other income/expenses net
-
-
-42
7
40
Income before tax
-93,720
-85,895
-68,867
-54,990
-39,495
Income from continuing operations
-93,720
-85,895
-68,867
-54,990
-39,495
Net income
-93,720
-85,895
-68,867
-54,990
-39,495
Net income available to common shareholders
-93,720
-85,895
-68,867
-54,990
-39,495
Basic EPS
-0.92
-0.91
-0.90
-0.71
-0.54
Diluted EPS
-0.92
-0.91
-0.90
-0.71
-0.54
Basic average shares
88,507
94,347
76,834
77,198
72,597
Diluted average shares
88,507
94,347
76,834
77,198
72,597